One week left to apply for the postdoc position in my lab at Oxford @ox.ac.uk
Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social.
Deadline: 11 August 2025 (noon).
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Research Highlight of our recent paper by @jieyang437.bsky.social on Aspirin and cancer metastasis in Nature Reviews Immunology. Thanks to Yvonne Bordon for a crystal clear account of the experimental findings www.nature.com/articles/s41...
New results from the ALASCCA prospective randomised controlled trial showing daily #aspirin reduces colorectal cancer recurrence by ~50% in patients with PIK3CA or related mutations. Findings extend benefits of aspirin beyond Lynch syndrome cancers to nearly 40% of CRCs ascopubs.org/doi/10.1200/...
Brilliant new paper from Jie Yang @jieyang437.bsky.social and Rahul Roychoudhuri @roychoudhurilab.bsky.social linking aspirin to immune-mediated prevention of cancer metastasis.
www.nature.com/articles/s41...
Congrats to @jieyang437.bsky.social & Rahul for this awesome work on metastasis
www.nature.com/articles/s41...
Inhibition of cyclooxygenase 1 releases T cells from immunosuppression by platelet-derived thromboxane A2, thereby enhancing the immune response against metastasis.
LBA125Background: Colorectal cancer (CRC) affects 1.9 million individuals globally each year. Among
patients with stage II-III CRC, 20-40% develop metastatic disease. Aspirin lowers
the incidence of a...
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis.
Deadline: 11 August 2025
my.corehr.com/pls/uoxrecru...
Lab info: www.oncology.ox.ac.uk/team/jie-yang
Inhibition of cyclooxygenase 1 releases T cells from immunosuppression by platelet-derived thromboxane A2, thereby enhancing the immune response against metastasis.
